Latest net tangible assets for ECTE: $-6.3M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Echo Therapeutics (ECTE) currently reports a net tangible assets of $-6.3M as of September 2016. That compares with $-1.9M in the prior-year period — down 237.5% year over year. Use the charts on this page to explore Echo Therapeutics's net tangible assets history and peer comparisons.
Echo Therapeutics's net tangible assets decreased from $-1.9M to $-6.3M — a 237.5% year-over-year decrease (period ending September 2016). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Echo Therapeutics reported $-6.3M in net tangible assets as of September 2016. That compares with $-1.9M in the prior-year period — down 237.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $-6.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Echo Therapeutics, and consider following ECTE for alerts when major investors trade the stock.